Viewing Study NCT05255666


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2026-01-31 @ 4:15 AM
Study NCT ID: NCT05255666
Status: WITHDRAWN
Last Update Posted: 2023-07-11
First Post: 2022-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
Sponsor: Washington University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
None Brain Metastases View
Keywords: